EAM
AQST icon

Everstar Asset Management’s Aquestive Therapeutics AQST Stock Holding History

Everstar Asset Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.3M Buy
553,181
+208,381
+60% +$846K 1.22% 14
2025
Q4 		$2.23M Sell
344,800
-23,489
-6% -$146K 1.19% 19
2025
Q3 		$2.06M Sell
368,289
-290,318
-44% -$1.26M 1.17% 21
2025
Q2 		$2.18M Buy
658,607
+358,607
+120% +$1.03M 1.33% 15
2025
Q1 		$870K Buy
300,000
+83,777
+39% +$254K 0.58% 45
2024
Q4 		$770K Sell
216,223
-183,902
-46% -$848K 0.54% 49
2024
Q3 		$1.99M Buy
+400,125
New +$1.56M 1.37% 14

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Everstar Asset Management's AQST Position: Q1 2026 in Review

Everstar Asset Management increased its Aquestive Therapeutics (AQST) stake by 60% in Q1 2026, buying an estimated $846K and bringing the position to 553,181 shares worth $2.3M. The position accounts for 1.22% of the portfolio, ranked #14.

Everstar Asset Management first reported a position in AQST in Q3 2024 and has held it in 7 quarters since. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Everstar Asset Management held 553,181 shares of Aquestive Therapeutics worth $2.3M as of Q1 2026.
  • Everstar Asset Management bought 208,381 Aquestive Therapeutics shares in Q1 2026, an estimated $846K.
  • Aquestive Therapeutics made up 1.22% of Everstar Asset Management's portfolio in Q1 2026, its #14 holding.
  • Everstar Asset Management first reported a position in Aquestive Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Everstar Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.